Video Wikipedia talk:WikiProject Pharmacology/Archive 14
Drug box 'us-license=' parameter
Just to make you aware, that apparently FDA seems to have changed the URL for searching NDA's or so. Clicking onto the us-license link in drug boxes does seem to not to work properly ... Wowbagger2 (talk) 17:23, 29 December 2017 (UTC)
- Yes, that link has unfortunately been broken since around January or February 2017 (special:diff/764891086/765098473). Seppi333 (Insert 2¢) 20:24, 29 December 2017 (UTC)
- Could not find any wisdom at the FDA site. (help)-DePiep (talk) 01:35, 30 December 2017 (UTC)
- I could. It would however need an update of how WP is accessing drug information at drugs@fda: at least with the NDA number, you can link to their website
- Copanlisib - https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=209936
- Acalabrutinib -
- Could not find any wisdom at the FDA site. (help)-DePiep (talk) 01:35, 30 December 2017 (UTC)
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=210259 I will try to explore if this can be done more general (e.g. using inn or tradename) in the next weeks. However, it might definitely need an update of the implementation of the drug box use of 'us-license' parameter. And of course - you need to be happy with accessing the pretty expert-like drug overview pages, by clicking on 'us-license'. (In contrast, the 'daily med' link can provide consumer information). -- Preceding unsigned comment added by Wowbagger2 (talk o contribs) 11:38, 30 December 2017 (UTC)
- OK. Do other people here think DailyMed is better/enough? IMO, we'd want a list by INN (one can get that manually, through page [1]). Note that our EMA link (Europe) works with INN (sometimes rewritten...). -DePiep (talk) 11:52, 30 December 2017 (UTC)
- @DePiep: Didn't you contact the USFDA about this issue earlier and get no response? Seppi333 (Insert 2¢) 03:33, 3 January 2018 (UTC)
- If I'm wrong about them having been contacted, I wouldn't mind sending them an email explaining the issue. Seppi333 (Insert 2¢) 03:34, 3 January 2018 (UTC)
- No I have not (ever). Infobox drug/licence shows no hints either, a new issue. What I did was switch off Canada because it does not work.
- Yes contact FDA please. IMO we could use the automated link (URL) to INN-licence info, so if that is "expert-like drug overview pages", that be so (re Wowbagger2). Code change no issue; did so recently with EMA licence (which goes by INN + per-article exception possible).
- To consider asking: if we can download complete lists (like in spreadsheet), we can put that in Wikidata! -DePiep (talk) 09:25, 3 January 2018 (UTC)
- Hi. Just to add a little, at FDA, drugs (e.g. Idelalisib), can have multiple NDA's (Idelalisib: 206545 AND 205858). this leads to two different pages (for same product), and while the latest label is identical, the review report and the letter (containing post marketing requirements) are not! Conclusion: INN for Usfda is not enough, compared to EMA, a list of NDA's would be more complete. -- Preceding unsigned comment added by Wowbagger2 (talk o contribs) 12:09, 4 January 2018 (UTC)
- @Garzfoth: After re-reading the thread I unarchived at Template talk:Infobox drug#licence_US parameter no longer works, I realized it was you that sent an email to the FDA about the non-functional drug search links. Did you ever receive a response from them about this? If so, what did they say? Seppi333 (Insert 2¢) 20:55, 4 January 2018 (UTC)
- @Seppi333: The FDA essentially never replied to the specific concern (the below message is the only response I ever got from them):
-
Thank you for writing the FDA. Please accept this response from the Small Business and Industry Assistance, Division of Drug Information, in the FDA's Center for Drug Evaluation and Research.
Thank you for bringing your concerns to our attention. We have had some recent changes to our Drugs@FDA website. Your inquiry has been forwarded to experts within the Agency for input and assistance. When we receive a response we will forward it to you, or they may contact you directly. Please understand that response times may vary. Thank you in advance for your patience. - Health Canada responded specifically to the issue I highlighted (unlike the FDA), but they essentially said that the behavior was intentional and they weren't going to change it, so no luck there either. Garzfoth (talk) 03:30, 9 January 2018 (UTC)
- @Wowbagger2: The USFDA link used to link to the USFDA search page results for the
|licence_US=
parameter input. E.g., the USFDA link for amphetamine used to bring up the search page with the list of 37 results that you would see if you searched the term "amphetamine" on this FDA drug search page. Some of those results are grouped under the same NDA/ANDA numbers, but a few of those results (specifically, the generic drug names), when clicked, display a large sub-list of different amphetamine pharmaceuticals with different ANDA numbers. Restoring that functionality would be ideal since any pharmaceutical drug that (1) has been in use for a long time, (2) is currently commonly prescribed in the United States, and (3) is no longer patented will have a similarly large number of search results as those for amphetamine. Seppi333 (Insert 2¢) 21:08, 4 January 2018 (UTC)
- @Garzfoth: After re-reading the thread I unarchived at Template talk:Infobox drug#licence_US parameter no longer works, I realized it was you that sent an email to the FDA about the non-functional drug search links. Did you ever receive a response from them about this? If so, what did they say? Seppi333 (Insert 2¢) 20:55, 4 January 2018 (UTC)
- I agree! Wowbagger2 (talk) 21:57, 4 January 2018 (UTC)
Maps Wikipedia talk:WikiProject Pharmacology/Archive 14
Category:Redirects from trade names has been nominated for discussion
Category:Redirects from trade names, which you created, has been nominated for renaming to Category:Redirects from trade names of drugs. A discussion is taking place to see if it abides with the categorization guidelines. If you would like to participate in the discussion, you are invited to add your comments at the category's entry on the categories for discussion page. Thank you.. --BrownHairedGirl (talk) o (contribs) 16:24, 18 January 2018 (UTC)
- See also Template talk:R from trade_name#Requested_move_18_January_2018. --BrownHairedGirl (talk) o (contribs) 16:29, 18 January 2018 (UTC)
Category:Clinical pharmacologists has been nominated for discussion
Category:Clinical pharmacologists, which is within the scope of this WikiProject, has been nominated for merge. A discussion is taking place to see if it abides with the categorization guidelines. If you would like to participate in the discussion, you are invited to add your comments at the category's entry on the categories for discussion page. Thank you. --BrownHairedGirl (talk) o (contribs) 01:57, 22 December 2017 (UTC)
-
- Note:The CFD was closed (Z)(p)(p)(i)(x) Talk 20:32, 25 January 2018 (UTC)
4th WP:FAC nomination of ?-Hydroxy ?-methylbutyric acid
Now that this article is a GA, I intend to re-nominate this article at FAC sometime within the next 2 weeks. When the following is no longer a red link - Wikipedia:Featured article candidates/Beta-Hydroxy beta-methylbutyric acid/archive4 - it would be very helpful and very much appreciated if other editors from this WikiProject would comment/review the article against the WP:Featured article criteria. It is incredibly difficult to get a pharmacology article promoted at FAC, and unless editors who are familiar with the subject matter (i.e., editors from WP:MED/WP:PHARM/WP:MCB) review and comment on a pharmacology nomination at FAC, it very likely will not be promoted. For instance, amphetamine required 5 consecutive featured article nominations before being promoted in WP:Featured article candidates/Amphetamine/archive5 for that very reason.
So, if you're an active editor at WT:PHARM and edit drug articles on a fairly regular basis, your input at the next nomination would be invaluable. Moreover, if any of you intends to nominate a drug article at FAC at some point in the future, reviewing another pharmacology nomination as well as reading the reviews by other editors at that nomination will give you a good idea of what to expect and prepare for at your own FAC nomination(s). Seppi333 (Insert 2¢) 22:50, 4 January 2018 (UTC)
- I re-nominated this article at FAC today: Wikipedia:Featured article candidates/Beta-Hydroxy beta-methylbutyric acid/archive4. Seppi333 (Insert 2¢) 07:32, 20 January 2018 (UTC)
- For those who haven't reviewed an article at FAC before, this is the "FAQ" page for reviewing articles at FAC. Seppi333 (Insert 2¢) 03:48, 2 February 2018 (UTC)
Source of the article : Wikipedia